Navigation Links
One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
Date:9/5/2007

ect the population of all physicians involved in menopause care.

To qualify for the survey, a physician had to devote at least 70% of their working day to clinical practice, see at least two patients with menopausal symptoms in a typical month and treat patients for at least six years post-residency or fellowship.

About The Hormone Foundation

The Hormone Foundation, the public education affiliate of The Endocrine Society, is a leading source of hormone-related health information for the public, physicians, allied health professionals and the media. Its mission is to serve as a resource for the public by promoting the prevention, treatment and cure of hormone-related conditions through outreach and education. For more information about The Hormone Foundation, please visit http://www.hormone.org.

About Novogyne Pharmaceuticals

Novogyne Pharmaceuticals is a joint venture between Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, and Noven Pharmaceuticals, Inc. of Miami, Florida. Since May 1998, Novogyne has been offering pharmaceutical products that enable physicians to better serve the medical needs of mature women. Novogyne was the first company in the U.S. offering transdermal systems for both the estrogen-only and combination estrogen/progestin markets. For more information about Novogyne Pharmaceuticals and its products, please visit http://www.novogyne.com.


'/>"/>
SOURCE The Hormone Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
2. Worlds Largest Cord Blood Bank to be started in India
3. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
4. Heart Related Problems-The Largest Killers In Andhra Pradesh
5. Children’s Center to Lead Largest-Ever Study on Kidney Disease in Childre
6. Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date
7. Missed Vaccination Caused Largest Measles Outbreak in U.S in 2005
8. Largest Ever African HIV Vaccine Trial Opens in South Africa
9. Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests
10. World Largest Hair Congress Convene in Vancouver
11. Largest Ever Study of Genetics Behind Common Diseases Published
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2Gentiva Reports Second Quarter 2009 Results 53196 1Gentiva Reports Second Quarter 2009 Results 53196 2Gentiva Reports Second Quarter 2009 Results 53196 3Gentiva Reports Second Quarter 2009 Results 53196 4Gentiva Reports Second Quarter 2009 Results 53196 5Gentiva Reports Second Quarter 2009 Results 53196 6Gentiva Reports Second Quarter 2009 Results 53196 7Gentiva Reports Second Quarter 2009 Results 53196 8Gentiva Reports Second Quarter 2009 Results 53196 9Gentiva Reports Second Quarter 2009 Results 53196 10Gentiva Reports Second Quarter 2009 Results 53196 11Gentiva Reports Second Quarter 2009 Results 53196 12Gentiva Reports Second Quarter 2009 Results 53196 13Gentiva Reports Second Quarter 2009 Results 53196 14Gentiva Reports Second Quarter 2009 Results 53196 15Gentiva Reports Second Quarter 2009 Results 53196 16BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 1BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 2BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 3BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 4BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 5BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 6BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 7BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 8BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 53194 9Caliper Life Sciences Reports Second Quarter 2009 Results 13273 1Caliper Life Sciences Reports Second Quarter 2009 Results 13273 2Caliper Life Sciences Reports Second Quarter 2009 Results 13273 3Caliper Life Sciences Reports Second Quarter 2009 Results 13273 4Caliper Life Sciences Reports Second Quarter 2009 Results 13273 5Caliper Life Sciences Reports Second Quarter 2009 Results 13273 6Caliper Life Sciences Reports Second Quarter 2009 Results 13273 7Caliper Life Sciences Reports Second Quarter 2009 Results 13273 8Caliper Life Sciences Reports Second Quarter 2009 Results 13273 9Caliper Life Sciences Reports Second Quarter 2009 Results 13273 10